MDM2 is an oncoprotein that blocks p53 tumor suppressor-mediated
transcriptional transactivation, escorts p53 from the cell nucleus to the
cytoplasm, and polyubiquitylates p53. Polyubiquitylated p53 is rapidly degraded
in the cytoplasm by the 26S proteasome. MDM2 is abnormally upregulated in
several types of cancers, especially those of mesenchymal origin. MDM4 is a
homolog of MDM2 that also inhibits p53 by blocking p53-mediated transactivation.
MDM4 is required for MDM2-mediated polyubiquitylation of p53 and is abnormally
upregulated in several cancer types. MDM2 and
MDM4 genes have been detected in all vertebrates to date
and only a single gene homolog, named MDM, has been detected in
some invertebrates. MDM2, MDM4, and
MDM have similar gene structures, suggesting that
MDM2 and MDM4 arose through a duplication
event more than 440 million years ago. All members of this small
MDM2 gene family contain a single really interesting new
gene (RING) domain (with the possible exception of lancelet MDM) which places
them in the RING-domain superfamily. Similar to MDM2, the vast majority of
proteins with RING domains are E3 ubiquitin ligases. Other RING domain E3
ubiquitin ligases that target p53 are COP1, Pirh2, and MSL2. In this report, we
present evidence that COP1, Pirh2, and MSL2 evolved independently of MDM2 and
MDM4. We also show, through structure homology models of invertebrate MDM RING
domains, that MDM2 is more evolutionarily conserved than MDM4.